The FDA and CDC are reviewing data involving six reported cases of blood clots, and the drugmaker said it would delay its European rollout. The White House Covid-19 coordinator said the pause won’t have a major effect on vaccination efforts.
The companies’ $16 billion deal is the latest sign that the next battleground for technology giants will be in healthcare, an industry whose need to embrace data and software was underscored by the pandemic.
The “superapp” operator said it would go public on the Nasdaq by merging with a special-purpose acquisition company, securing a near-$40 billion valuation in a new milestone for the SPAC boom that has swept markets.
President Xi Jinping is confronting the Biden administration with a new world view, that Beijing’s decades of not challenging the U.S. as the global leader are over; “no room for compromise” on Taiwan.